Comparative Analysis of Diabetic Ketoacidosis in Adults With Type 1 and Type 2 Diabetes Mellitus: Insights From a Saudi Arabian Cohort. [PDF]
Alali SA+10 more
europepmc +1 more source
SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA Adverse Event Reporting System
G. Fadini, B. Bonora, A. Avogaro
semanticscholar +1 more source
ABSTRACT Aims To investigate the impact of Sydney's COVID‐19 lockdown on children with developmental disadvantages and reflect on current clinical practice. Methods Retrospective data was collected from a western Sydney metropolitan hospital's electronic database and patients. We reviewed all children with Autism Spectrum Disorder (ASD), Cerebral Palsy
Lanxin Li, Habib Bhurawala, Anthony Liu
wiley +1 more source
Unmasking Euglycemic Diabetic Ketoacidosis: The Interplay of Pregnancy, Sepsis, and Glucagon-Like Peptide 1 Analog. [PDF]
Huang A+6 more
europepmc +1 more source
The Current Landscape for Screening and Monitoring of Early‐Stage Type 1 Diabetes
ABSTRACT Type 1 diabetes (T1D) has two pre‐symptomatic phases (stages 1 and 2) with progressive destruction of beta cells which have been identified through longitudinal cohort studies in recent decades. The definition of T1D, with hyperglycaemia that may or may not be symptomatic, is now defined as stage 3. There is growing evidence that screening for
Kruthika Narayan+4 more
wiley +1 more source
Diabetic Ketoacidosis in an Undiagnosed Type 1 Diabetic: A Case Study Highlighting Barriers to Rural Healthcare Access. [PDF]
Alhameed MS, Rocha CF.
europepmc +1 more source
A Case of Euglycemic Diabetic Ketoacidosis Associated With a Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor. [PDF]
Hedary A, Melder L, Pippin M.
europepmc +1 more source
Diabetic Ketoacidosis Associated with Guillain-Barre Syndrome with Autonomic Dysfunction.
S Fujiwara+7 more
openalex +2 more sources
Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data
J. Blau+3 more
semanticscholar +1 more source